Keenova Therapeutics plc Total Contract Liability
Keenova Therapeutics plc had Total Contract Liability of $282.10 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-08-11
- 2026-06-30: Contract with Customer, Liability $282.10M.
- 2026-03-31: Contract with Customer, Liability $270.90M.
- 2025-12-31: Contract with Customer, Liability $284.50M.
- 2025-09-26: Contract with Customer, Liability $662.30M.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2026-06-30 | $282.10M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $270.90M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $284.50M 10-Q · filed 2026-08-11 | |
| 2025-09-26 | $662.30M 10-Q · filed 2025-11-10 | |
| 2025-06-27 | $97.30M 10-Q · filed 2026-08-11 | |
| 2025-03-28 | $82.90M 10-Q · filed 2026-05-12 | |
| 2024-12-27 | $69.30M 10-Q · filed 2026-08-11 | $228.80M 10-Q · filed 2025-11-10 |
| 2024-09-27 | $235.50M 10-Q · filed 2025-11-10 | |
| 2023-12-29 | $98.00M 10-K · filed 2026-04-15 | $227.40M 10-Q · filed 2025-11-10 |
| 2023-11-14 | $79.90M 10-K · filed 2026-04-15 | |
| 2022-12-30 | $146.60M 10-K · filed 2026-04-15 | |
| 2020-12-25 | $3.10M 10-K · filed 2021-03-10 | |
| 2020-09-25 | $3.40M 10-Q · filed 2020-11-03 | |
| 2020-06-26 | $3.80M 10-Q · filed 2020-08-04 | |
| 2020-03-27 | $5.30M 10-Q · filed 2020-05-06 | |
| 2019-12-27 | $6.20M 10-K · filed 2021-03-10 | |
| 2019-09-27 | $6.50M 10-Q · filed 2019-11-05 | |
| 2019-06-28 | $37.20M 10-Q · filed 2019-08-06 | |
| 2019-03-29 | $35.70M 10-Q · filed 2019-05-07 | |
| 2018-12-28 | $35.50M 10-K · filed 2020-02-26 | |
| 2018-09-28 | $35.20M 10-Q · filed 2018-11-06 | |
| 2018-06-29 | $25.40M 10-Q · filed 2018-08-07 | |
| 2018-03-30 | $18.80M 10-Q · filed 2018-05-08 | |
| 2017-12-29 | $20.60M 10-K · filed 2019-02-26 | $20.20M 10-Q · filed 2018-05-08 |